HBI
31
-6
MS
62
7
MA
65
-2
TDC
23
2
CLX
62
-2
HST
32
2
L
39
-2
GT
51
22
PM
68
2
PAYX
44
-6
UNH
38
-4
VMC
48
10
CMS
61
-6
TRV
34
-2
ILMN
11
2
MTB
55
5
LLY
60
-14
NTAP
54
2
LB
53
3
CSX
43
2
HBI
31
-6
MS
62
7
MA
65
-2
TDC
23
2
CLX
62
-2
HST
32
2
L
39
-2
GT
51
22
PM
68
2
PAYX
44
-6
UNH
38
-4
VMC
48
10
CMS
61
-6
TRV
34
-2
ILMN
11
2
MTB
55
5
LLY
60
-14
NTAP
54
2
LB
53
3
CSX
43
2
Financhill
Back

Nu Skin Enterprises 10K Form

Buy
54

NUS
Nu Skin Enterprises

Last Price:
$7.55
Seasonality Move:
4.36%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-09 10Q NUS/Nu Skin Enterprises Quarterly
2023-11-02 10Q NUS/Nu Skin Enterprises Quarterly
2023-08-02 10Q NUS/Nu Skin Enterprises Quarterly
2023-05-04 10Q NUS/Nu Skin Enterprises Quarterly
2022-11-03 10Q NUS/Nu Skin Enterprises Quarterly
2022-08-05 10Q NUS/Nu Skin Enterprises Quarterly

Receive NUS News And Ratings

See the #1 stock for the next 7 days that we like better than NUS

NUS Financial Statistics

Sales & Book Value

Annual Sales: $1.7B
Cash Flow: $22.8M
Price / Cash Flow: 5.35
Annual Sales: $13.08
Price / Book: 0.58

Profitability

EPS (TTM): -2.95000
Net Income (TTM): $-146.6M
Gross Margin: $1.2B
Return on Equity: -19.94%
Return on Assets: -8.95%

Nu Skin Enterprises Earnings Forecast

Key Nu Skin Enterprises Financial Ratios

  • The Gross Profit Margin over the past 30 years for NUS is 68.23%.
  • The Selling, General & Administrative Expenses for NUS have been equal to 65.30% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Net Earning history of NUS is -8.46% of Total Revenues.
  • Per Share Earnings over the last 30 years have been positive in 15 years.

Nu Skin Enterprises Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Personal Care Products
Sector: Consumer Staples
Current Symbol: NUS
CUSIP: 67018T
Website: nuskin.com

Debt

Debt-to-Equity Ratio: 0.6
Current Ratio: 1.82
Quick Ratio: 0.84

Price-to-Earnings

Trailing P/E Ratio: 37.76
Forward P/E Ratio: 5.36

NUS Technical Analysis vs Fundamental Analysis

Buy
54
Nu Skin Enterprises (NUS) is a Buy

Is Nu Skin Enterprises a Buy or a Sell?